Research & facilities
Glasgow is a world leader in innovative and cutting-edge biomedical research. Glasgow has risen to the challenges of the modern age by establishing the Glasgow BioCorridor which is enhancing the city’s offer and ensuring that the impetus toward major research and discoveries continues. With strong public-private collaboration in place, the BioCorridor offers unparalleled opportunities for commercialising R&D findings.
A number of research facilities and collaborations exist or are planned for Glasgow. Some examples include:
- Stratified Medicine Scotland Innovation Centre, which is a collaboration with Life Technologies, Aridhia and the NHS, other biotech and pharma companies and small to medium sized businesses, to be located at the publicly funded Queen Elizabeth University Hospital Campus (QEUH). Glasgow’s expertise in this field has secured investments exceeding £70 million, enabling exciting new collaborations across the “triple helix” of academic research, the NHS and private industry. In terms of economic impact to the city, Stratified Medicine activities at the QEUH are expected to create 500 new jobs and generate £100 million in GVA over the next 10 years.
- Glasgow Biomedicine is a cooperation among the University of Glasgow and six Glasgow hospital sites. The aim is to create an interdisciplinary centre of excellence to manage commercial and non-commercial clinical trial research. The Glasgow Clinical Trials Unit will initiate more than 600 new trials per year and support more than 1,500 trials. An average of close to £15.5 million is spent conducting this research on an annual basis. One unique aspect of Glasgow Biomedicine is its ability to link its collected data with information from the patient-related Community Health Index (CHI) number used in Scotland for all health-related communications to derive detailed patient-related analysis and follow-up.
- Glasgow Clinical Research Facility (CLF), founded in 2006 by an NHS Clinical Research Grant Agreement, works together with institutes of higher education and provides the clinical infrastructure to undertake high quality research.
- Ensuring that the R&D outcomes come to fruition, NHS Research Scotland Permissions Coordinating Centre (NRS-PCC) enables fast R&D approvals following clinical trials of less than a month for both commercial and non-commercial projects.
- NHS Greater Glasgow and Clyde Tissue Bio-repository located at the new South Glasgow Hospital is actively engaged in the future translation of research for patient benefit.
- The Strathclyde Institute for Pharmacy and Biomedical Studies is leading drug development for a variety of diseases and ailments, including cancer drugs.
- The Strathclyde Institute of Medical Devices, located at the bioengineering department of Strathclyde University, is an interdisciplinary unit that partners with the NHS to undertake research and apply it to medtech issues and to bring global medical technologies to market. Medtech is a core subsector for Glasgow.
- The Institute of Cancer Sciences makes up a major part of the Cancer Research UK West of Scotland Cancer Centre and together with Beatson Institute for Cancer Research is the core cancer research institution in Glasgow.
- Glasgow City of Science is a wide-ranging partnership that brings together public and civil sector forces with academia and local industry to promote basic science, technology, engineering, art, design, maths, medicine and social sciences (STEAMMS) within Glasgow and the West of Scotland. This initiative crosses into multiple disciplines and sectors all with the aim of finding ways to improve and enhance the lives of citizens of Glasgow by undertaking work in these varied fields.